⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1397373 | 0.67 | — | — | |
| SCHEMBL10009143 | 0.55 | — | — | |
| SCHEMBL1149540 | 0.55 | — | — | |
| SCHEMBL221803 | 0.55 | — | — | |
| SCHEMBL17203678 | 0.55 | — | — | |
| Hydrochloric Acid SCHEMBL31261787 | 0.54 | — | — | |
| SCHEMBL31540574 | 0.54 | — | — | |
| Pyridazine SCHEMBL449549 | 0.47 | — | — | |
| SCHEMBL2384 | 0.47 | — | — | |
| SCHEMBL6276848 | 0.45 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1306 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024115549-A1 | ARYL- AND HETEROARYL-SULFONAMIDE DERIVATIVES AS CCR8 MODULATORS | IDORSIA PHARMACEUTICALS LTD (CH) | 2024-06-06 | — | — | WO | claimed |
| CN-118139837-A | Stilbene derivative, preparation method and application thereof | 上海泽德曼医药科技有限公司 | 2024-06-04 | — | — | CN | claimed |
| CN-112888696-B | Exonuclease inhibitors and methods of use thereof | 德琪医疗有限公司 | 2024-04-16 | — | — | CN | claimed |
| WO-2024061187-A1 | STILBENE DERIVATIVES AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF | 上海泽德曼医药科技有限公司 | 2024-03-28 | — | — | WO | claimed |
| US-20240043435-A1 | TYK-2 INHIBITOR | BEONE MEDICINES I GMBH (CH) | 2024-02-08 | — | — | US | claimed |
| US-20230338429-A1 | COMPOUNDS AND USE THEREOF IN THE EXPANSION OF STEM CELLS AND/OR PROGENITOR CELLS | UNIVERSITE DE MONTREAL (CA) | 2023-10-26 | — | — | US | claimed |
| EP-4168398-A1 | TYK-2 INHIBITOR | BeiGene, Ltd. (KY) | 2023-04-26 | — | — | EP | claimed |
| WO-2023025783-A1 | SMALL MOLECULE MODULATORS OF IL-17 | LEO PHARMA A/S (DK) | 2023-03-02 | — | — | WO | claimed |
| CN-115715288-A | TYK-2 inhibitors | 百济神州有限公司 | 2023-02-24 | — | — | CN | claimed |
| CN-114901284-A | Methods of treating cancer in patients identified by biomarkers with cyclin dependent kinase 7(CDK7) inhibitors | 希洛斯医药品股份有限公司 | 2022-08-12 | — | — | CN | claimed |
| CN-1061966-A | Contain herbicidal composition of uracil derivative and preparation method thereof | NISSAN CHEMICAL IND LTD (JP) | 1992-06-17 | — | — | CN | claimed |
| WO-1991006542-A1 | PHARMACEUTICALLY ACTIVE AMINO-SUBSTITUTED HETEROARYL AMINES | THE UPJOHN COMPANY (US) | 1991-05-16 | — | — | WO | claimed |
| CN-1046903-A | Process for preparing heterocyclic ether derivatives | ICI PLC (GB) | 1990-11-14 | — | — | CN | claimed |
| EP-0396282-A2 | N-aryl-N-[4-(heterocyclicalkyl) piperidinyl]amides and pharmaceutical compositions and methods employing such compounds | BOC, INC. (US) | 1990-11-07 | — | — | EP | claimed |
| EP-0306148-A2 | Azabicyclic ethers | JOHN WYETH & BROTHER LIMITED (GB) | 1989-03-08 | — | — | EP | claimed |
| CN-1031532-A | HETEROCYCLIC COMPOUNDS | WELLCOME FOUND (GB) | 1989-03-08 | — | — | CN | claimed |
| EP-0055583-B1 | ANTIHYPERTENSIVES | Pfizer Limited (GB) | 1985-08-28 | — | — | EP | claimed |
| US-4439225-A | Herbicidal cyano-tetrahydrofuranylmethyl ether and cyano-tetrahydropyranylmethyl ether derivatives | SHELL OIL COMPANY (US) | 1984-03-27 | — | — | US | claimed |
| US-4419363-A | ADRENERGIC BLOCKING AGENTS | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1983-12-06 | — | — | US | claimed |
| US-4273782-A | FOR USE IN CARDIOVASCULAR DISORDERS AND COMPLICATIONS OF DIABETES | PFIZER INC. (US) | 1981-06-16 | — | — | US | claimed |